Correspondence 0001437749-24-022765 from DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc.
Date: July 16, 2024 · CIK: 0001401040 · Accession: 0001437749-24-022765
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280744
Letter
dmtp20240715_corresp.htm
DIAMEDICA THERAPEUTICS, INC.
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS, MN 55305 USA
T 763 496 5454
E INFO@DIAMEDICA.COM
W WWW.DIAMEDICA.COM
July 16, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, DC 20549
Attention: Tyler Howes
Re:
DiaMedica Therapeutics Inc.
Registration Statement on Form S-3
Filed July 10, 2024
File No. 333-280744
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, DiaMedica Therapeutics Inc. (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on July 18, 2024, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Amy Culbert of Fox Rothschild LLP at (612) 607-7287.
Thank you for your assistance in this matter. Should you have any questions, please call Ms. Culbert.
Very truly yours,
/s/ Rick Pauls
Show Raw Text
CORRESP 1 filename1.htm dmtp20240715_corresp.htm DIAMEDICA THERAPEUTICS, INC. 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS, MN 55305 USA T 763 496 5454 E INFO@DIAMEDICA.COM W WWW.DIAMEDICA.COM July 16, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Tyler Howes Re: DiaMedica Therapeutics Inc. Registration Statement on Form S-3 Filed July 10, 2024 File No. 333-280744 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, DiaMedica Therapeutics Inc. (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on July 18, 2024, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Amy Culbert of Fox Rothschild LLP at (612) 607-7287. Thank you for your assistance in this matter. Should you have any questions, please call Ms. Culbert. Very truly yours, /s/ Rick Pauls Rick Pauls President and Chief Executive Officer